Priyanka Vallabhaneni

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

Ahmad A. Tarhini, Yan Lin, Lin Huang et al. · Journal for ImmunoTherapy of Cancer · 2018 · 61 citations · Full text

Medicine, Immunology, Oncology +17

Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit

Ahmad A. Tarhini, Yan Lin, Hui-Min Lin et al. · OncoImmunology · 2016 · 53 citations · Full text

Medicine, Cancer Biology, Oncology +17

Metronidazole Induced Liver Injury: A Rare Immune Mediated Drug Reaction

Dayakar Kancherla, Mahesh Gajendran, Priyanka Vallabhaneni et al. · Case Reports in Gastrointestinal Medicine · 2013 · 21 citations · Full text

Pharmacy, Immunology, Pharmacology +15